Forte Biosciences, Inc..
FBRX.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Forte Biosciences, Inc. is a biopharmaceutical company. It focuses on the development of therapies for autoimmune diseases. The company's lead product candidate is FB-102, a clinical-stage intravenous protein, which is in Phase 2 clinical trials for the treatment of atopic dermatitis. Forte Bioscien...Show More
Better Health for All
0
No evidence available to assess Forte Biosciences, Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
Forte Biosciences, Inc. is a biopharmaceutical company focused on developing therapies for autoimmune diseases, as evidenced by its clinical trials for FB102.
1
The provided articles detail its research and development expenses, financial results, and public stock offerings. There is no evidence to suggest that the company engages in lending, insurance, or other financial services for consumers. Therefore, all KPIs related to fair money and economic opportunity, which assess financial institutions, are not applicable to Forte Biosciences.
Fair Pay & Worker Respect
0
As of March 15, 2022, Forte Biosciences, Inc. had 5 full-time employees.
1
Due to this small workforce size, there is insufficient data to meaningfully assess living wage coverage or employee turnover, resulting in a neutral score for both.
2
None of Forte's employees are represented by labor unions or covered by collective bargaining agreements, which is also considered neutral given the small workforce and absence of evidence of anti-union tactics.
3
While the company uses contract manufacturing and testing organizations, there is no data on the share of its *workforce* on insecure contracts, leading to a neutral score for this KPI.
4
Fair Trade & Ethical Sourcing
0
No evidence available to assess Forte Biosciences, Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No evidence available to assess Forte Biosciences, Inc. on Honest & Fair Business.
Kind to Animals
0
The company is not involved in animal agriculture or the production of animal-derived products.
1
No War, No Weapons
0
The provided articles for Forte Biosciences, Inc. (FBRX.US) focus on financial results, SEC filings, and clinical development updates for its biopharmaceutical products. None of the articles contain any explicit information or data points related to arms manufacturing, military contracts, dual-use technologies, sales to embargoed regimes, peacebuilding investments, or any other specific metrics under the 'No War, No Weapons' ethical value. Therefore, no KPIs can be scored based on the provided evidence.
Planet-Friendly Business
0
No specific, concrete data points or facts related to 'Planet-Friendly Business' KPIs were found across the provided articles.
1
The articles either explicitly state that no information is available for environmental metrics or detail financial transactions and general ethical codes of conduct without providing any environmental performance data.
2
Respect for Cultures & Communities
0
No specific, concrete data points related to Respect for Cultures & Communities were found across the provided articles for Forte Biosciences, Inc.
1
The articles primarily focus on financial performance, clinical trials, intellectual property, and corporate governance. Therefore, no KPIs can be scored based on the available evidence.
Safe & Smart Tech
0
No specific, concrete evidence was found in the provided articles for Forte Biosciences, Inc. (FBRX.US) that could be mapped to the quantitative thresholds of any KPI within the 'Safe & Smart Tech' rubric. The articles either pertained to a different entity (Forté Foundation)
1
, contained only general statements about security measures without specific data (e.g., 'employee training is mentioned')
2
, or explicitly stated that no relevant data was provided for the key metrics.
3
Zero Waste & Sustainable Products
0
No specific quantitative data related to waste diversion, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, zero-waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education is provided in the available articles.
1